Insider Transactions in Q3 2022 at Marrone Bio Innovations Inc (MBII)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 12
2022
|
Amit Vasavada SVP & CTO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
285,892
-100.0%
|
-
|
Jul 12
2022
|
Amit Vasavada SVP & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
129,184
+31.12%
|
-
|
Jul 12
2022
|
Timothy B Johnson VP (Field and Technical) |
SELL
Sale (or disposition) back to the issuer
|
Direct |
212,374
-100.0%
|
-
|
Jul 12
2022
|
Timothy B Johnson VP (Field and Technical) |
BUY
Grant, award, or other acquisition
|
Direct |
102,167
+32.48%
|
-
|
Jul 12
2022
|
Ospraie Ag Science LLC Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
70,836,258
-100.0%
|
-
|
Jul 12
2022
|
Keith Pitts SVP & Chief Sust. Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
221,437
-100.0%
|
-
|
Jul 12
2022
|
Keith Pitts SVP & Chief Sust. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102,950
+31.74%
|
-
|
Jul 12
2022
|
Linda V Moore Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
450,839
-100.0%
|
-
|
Jul 12
2022
|
Linda V Moore Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
316,153
+41.22%
|
-
|
Jul 12
2022
|
Matti Tiainen SVP, International Sales |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,684
-100.0%
|
-
|
Jul 12
2022
|
Matti Tiainen SVP, International Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,850,521
-100.0%
|
-
|
Jul 12
2022
|
Robert A Woods Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
468,527
-100.0%
|
-
|
Jul 12
2022
|
Robert A Woods Director |
BUY
Grant, award, or other acquisition
|
Direct |
455,027
+49.27%
|
-
|
Jul 12
2022
|
Yogesh Mago Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
321,770
-100.0%
|
-
|
Jul 12
2022
|
Yogesh Mago Director |
BUY
Grant, award, or other acquisition
|
Direct |
321,770
+50.0%
|
-
|
Jul 12
2022
|
Zachary S. Wochok Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,000
-100.0%
|
-
|
Jul 12
2022
|
Zachary S. Wochok Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
429,881
-100.0%
|
-
|
Jul 12
2022
|
Zachary S. Wochok Director |
BUY
Grant, award, or other acquisition
|
Direct |
429,081
+49.95%
|
-
|
Jul 12
2022
|
Keith Mc Govern Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
273,643
-100.0%
|
-
|
Jul 12
2022
|
Keith Mc Govern Director |
BUY
Grant, award, or other acquisition
|
Direct |
273,643
+50.0%
|
-
|
Jul 12
2022
|
Lara L Lee Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
167,812
-100.0%
|
-
|
Jul 12
2022
|
Lara L Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
167,812
+50.0%
|
-
|
Jul 12
2022
|
Kevin Helash Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
241,568
-100.0%
|
-
|
Jul 12
2022
|
Pamela G Marrone Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,442
-100.0%
|
-
|
Jul 12
2022
|
Pamela G Marrone Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,394,141
-100.0%
|
-
|
Jul 12
2022
|
Pamela G Marrone Director |
BUY
Grant, award, or other acquisition
|
Direct |
195,007
+7.53%
|
-
|
Jul 06
2022
|
Pamela G Marrone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.9%
|
$0
$0.8 P/Share
|